NEUROCRINE
Live / Registered — Registered (as of 11 Feb 2025)
What this means for you
Registered since 11 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98975517
- Registration number
- 7690781
- Mark type
- Stylized text
- Filed
- 21 Sept 2023
- Published for opposition
- 18 Jun 2024
- Registered
- 11 Feb 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of Huntington's Disease, chorea associated with Huntington's Disease
- Class 044 — Medical, beauty and agricultural services: Providing medical information; Providing medical information in the field of endocrine, hormonal, and genetic diseases, disorders, and conditions; providing medical information in the field of psychiatric, neurological, central nervous system, and movement diseases, disorders, and conditions; Providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Sept 2024 — USE AMENDMENT FILED
- 17 Jan 2025 — DIVISIONAL PROCESSING COMPLETE